We present a method for the enantioselective analysis of albendazole s
ulfoxide (ABZSO) in plasma for application in clinical pharmacokinetic
studies. ABZSO enantiomers were separated on a 5-mu m Chiralcel OB-H(
R) column (4.6 x 150 mm) using hexane:ethanol (93:7, v/v) as the mobil
e phase and fluorescence detection. ABZSO was extracted with chlorofor
m:isopropanol (8:2, v/v) from 500-mu l aliquots of acidified plasma, w
ith full drug recovery. The proposed method presented quantitation lim
its of 20 ng/ml for (-)ABZSO and 50 ng/ml for (+)ABZSO and was linear
up to a concentration of 5,000 ng/ml of each enantiomer. (C) 1997 Wile
y-Liss, Inc.